Key result
Norepinephrine escalation in septic shock does not alter short-term RV-PA coupling.
Why the study?
Although norepinephrine improves LV function in septic shock despite increasing LV afterload, uncertainty remained about its effects on RV function and RV-PA coupling.
Does norepinephrine initiation or dose escalation alter short-term right ventricle-pulmonary artery (RV-PA) coupling in patients with septic shock?
Cohort (n=53)
Does norepinephrine initiation or dose escalation alter short-term right ventricle-pulmonary artery (RV-PA) coupling in patients with septic shock?
Norepinephrine titration to restore mean arterial pressure in septic shock increases both PASP and RV contractility (TAPSE, S') proportionally, preserving short-term RV-PA coupling regardless of baseline RV function.
Answers are grounded in this paper and cite their sources.
Supports norepinephrine titration in septic shock without RV-PA uncoupling; leaves open need for randomized confirmation before practice change.
Background Norepinephrine (NE) is the first-line vasopressor in septic shock. It causes systemic and pulmonary vasoconstriction. NE has been shown to improve left ventricle (LV) function in septic shock despite an LV afterload increase, uncertainty remains about its effects on the right ventricular (RV) function and right ventricle-pulmonary artery (RV-PA) coupling. Methods This secondary analysis combined two prospective observational cohorts including patients with septic shock requiring initiation or increase of NE because of arterial hypotension. Transthoracic echocardiography was performed immediately prior to the initiation or to an increase of NE (T0), and then one hour after hemodynamic stabilization (mean arterial pressure (MAP) > 65 mmHg) (T1). RV-PA coupling was assessed using ratios of tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (PASP) (TAPSE/PASP) and tricuspid annular tissue Doppler systolic velocity (S’) to PASP (S’/PASP). Exploratory subgroup analyses were performed according to cardiac output (CO) response (≥12% increase) and baseline RV systolic function. Results Fifty-three patients were included. NE dose increased from 0.20 [0.00-0.35] to 0.42 [0.27-0.78] µg/kg/min, with significant increases in MAP, left ventricle ejection fraction (LVEF), CO, PASP, TAPSE and S’. Despite the increase in PASP, RV-PA coupling remained unchanged: TAPSE/PASP: 0.59 [0.40–0.81] vs. 0.58 [0.42–0.90] (p = 0.15), and S’/PASP: 0.43 [0.29–0.67] vs. 0.46 [0.28–0.67] (p = 0.56). Similar findings were observed regardless of baseline RV systolic function and irrespective of CO response to NE. Conclusion NE dose escalation to correct arterial hypotension was not associated with short-term alteration in RV–PA coupling. The absence of deleterious effect was consistent regardless of CO response and baseline RV systolic function. Further studies are warranted to assess the long-term effects of NE on RV–PA coupling and clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Théry et al. (2026) conducted a cohort in Septic shock with arterial hypotension (n=53). Norepinephrine initiation or dose escalation vs. Baseline immediately prior to initiation or increase of norepinephrine (T0) was evaluated on Right ventricle-pulmonary artery (RV-PA) coupling assessed by TAPSE/PASP ratio (p=0.15). Norepinephrine dose escalation in septic shock did not alter short-term RV-PA coupling.
Synapse has enriched 10 related papers. Consider them for comparative context: